Sulkowski, Parker L. http://orcid.org/0000-0002-5745-1158
Oeck, Sebastian http://orcid.org/0000-0001-9695-8771
Dow, Jonathan http://orcid.org/0000-0003-1354-1124
Economos, Nicholas G. http://orcid.org/0000-0003-4691-808X
Mirfakhraie, Lily
Liu, Yanfeng
Noronha, Katelyn
Bao, Xun
Li, Jing
Shuch, Brian M.
King, Megan C. http://orcid.org/0000-0002-1688-2226
Bindra, Ranjit S.
Glazer, Peter M. http://orcid.org/0000-0003-4525-5560
Article History
Received: 1 February 2019
Accepted: 28 April 2020
First Online: 3 June 2020
Competing interests
: R.S.B., P.M.G. and P.L.S. are inventors on US patent application no. 62/344,678 submitted by and assigned to Yale University, which covers compositions and methods for targeting and treating HDR-deficient tumours. P.M.G and R.S.B are founders of and consultants for Cybrexa Therapeutics. P.M.G. is a consultant for pHLIP. Neither company has any conceptual or financial connection to this manuscript.